(Z)-3-((3,5-二甲基-1H-吡咯-2-基)亚甲基)二氢吲哚-2-酮
2H-Indol-2-one,3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-1,3-dihydro-, (3Z)-;(Z)-3-((3,5-Dimethyl-1H-pyrrol-2-yl)methylene)indolin-2-one;Semaxanib;Semaxanib (SU5416);[14C]-Sematilide hydrochloride;3-(3,5-dimethylpyrrol-2-ylmethylidene)-2-indolinone;3-[(2,4-Dimethylpyrrol-5-yl)methylene]-2-indolinone;Benzamide, N-(2-(diethylamino)ethyl)-4-((methylsulfonyl)amino)-, monohydrochloride;N-(2-(Diethylamino)ethyl)-4-((methylsulfonyl)amino)benzamide monohydrochloride;N-[2-(diethylamino)ethyl]-4-[(methylsulfonyl)amino]benzamide hydrochloride;Sematilide hydrochloride (USAN);Sematilide monohydrochloride;(Z)-SU 5416;TSU 16;3-[(3,5-Dimethyl-1H-pyrrol-2-yl)methylene]-1,3-dihydro-2H-indol-2-one;17022(Z);Unii-71ia9S35aj;SeMaxanib,SU5416;Semaxanib (Z)-SU 5416;3-[(2,4-Dimethylpyrrol-5-yl)methylidenyl]-2-indolinon;3-((2,4-DIMETHYLPYRROL-5-YL)METHYLIDENYL)-2-INDOLONONE;3-((Z)-(3,5-Dimethylpyrrol-2-yl)methylene)-2-indolinone;Semaxinib;SU5416;SU 5416;Semoxind;VEGF Receptor 2 Kinase Inhibitor III;VEGFR2 Kinase Inhibitor III;71IA9S35AJ;3-(1-(3,5-Dimethyl-1H-pyrrol-2-yl)meth-(Z)-ylidene)-2-oxo-2,3-dihydroindole;(3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one;3-[(2,4-Dimethylpyrrol-5-yl)methylidene]-indolin-2-one;3-